Results

Total Results: 2,212 records

Showing results for "drug".

121. Migraine patients in the ER receive various IV medications from different ER doctors within the physician group. As I have watched particular drug combinations given to my patients and to my daughter in the ER, I have witnessed total… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/migraine-patients-in-the-er-receive-various-iv-medications-from-different-er-doctors-within-the-physician-group-as-i-have-watched-particular-drug-combinations-given-to-my-patients-and-to-my-daughter-in-the-er-i-have-witnesse
     November 01, 2017 - As I have watched particular drug combinations given to my patients and to my daughter in the ER, I have … As I have watched particular drug combinations given to my patients and to my daughter in the ER, I have … As I have watched particular drug combinations given to my patients and to my daughter in the ER, I have … An older drug, DHE, an ergot, often causes nausea and additional anti nausea meds are then required. … Appropriateness for EHC Program Does your question include a health care drug, intervention, device

122. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/adhd-medicines-risks/abstract
     December 01, 2019 - Doubts about the safety of ADHD drug use were raised recently by a U.S. … Food and Drug Administration review of its Adverse Event Reporting System (AERS) for cases of sudden … manuscript will describe the group’s experience in pulling data from multiple sites and sources for drug … [Epub ahead of print] FDA Drug Safety Communication: Safety review update of medications used to treat

123. Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric
     March 01, 2021 - Evidence Reports SHARE: Drug … March 2021 Page originally created December 2020 Internet Citation: Drug

124. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update
     March 01, 2021 - Evidence Reports SHARE: Drug … March 2021 Page originally created December 2020 Internet Citation: Drug

125. Adaptation of Data Mining Algorithms Assessing the Comparative Effectiveness and Safety of NSAIDs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/nsaids-safety-data-mining/research
     November 01, 2017 - Abstract Introduction Bayesian data mining methods have been used to evaluate drug safety signals … Geometric Mean ratio 1.85) and several other diagnoses that likely represented indications for the drug … Discussion Bayesian data mining methods seem useful to evaluate drug safety using administrative data … Further work will be needed to extend these findings to different types of drug exposures and to other … Food and Drug Administration (FDA)-approved ERT for the treatment of six LSDs.

126. Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular Data Registry | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/coronary-stents-outcomes/research
     January 01, 2020 - United States Food and Drug Administration. FDA Statement on coronary drug-eluting stents. … United States Food and Drug Administration. … Update to FDA statement on coronary drug-eluting stents. … Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. … An Observational Study of Drug-Eluting Versus Bare-Metal Stents.

127. Dietary-Supplements Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - patients’ supplement use.15,16 While a substantial amount of research and data is available describing drug–drug … Clinical cardiovascular effectiveness/efficacy of cardiovascular drug(s) plus supplement versus drug … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug … Pharmacokinetic outcomes with cardiovascular drug(s) plus supplement versus drug(s) plus placebo, no … involved in drug metabolism.

128. Financing and Economics of Conducting N-of-1 Trials (Chapter 3) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014-2
     August 01, 2019 - that qualified for inclusion in the study 6 and the degree to which the benefits and risks of the drug … drug B, and dose A versus dose B of the same drug. … Single-patient drug trial methodology for allergic rhinitis. … Drug safety on trial. … drug safety even after approval.

129. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - Harms results are organized by drug class. … ); NS = nonsteroidal anti-inflammatory drug; nsNSAID = nonselective nonsteroidal anti-inflammatory drug … Administration warnings, drug information texts). … Food and Drug Administration website. … Food and Drug Administration website.

130. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Drug Enforcement Administration (DEA) designated lorcaserin as a Schedule IV drug, which removed the … The drug has been classified by DEA as a Schedule IV drug; it became available for prescribing in June … Drug Enforcement Administration (DEA) as a Schedule IV drug (i.e., with a low potential for abuse … It was the first drug approved to treat obesity since 1999.69,71,73 However, FDA referred the drug … FDA approves Qsymia, a weight-loss drug. [internet].

131. Who Uses Exenatide For Glucose Control in Diabetes Mellitus? A Retrospective Cohort Study of a New Therapy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-glucose-control/research
     January 01, 2020 - Health, Department of Epidemiology Abstract Background: Exenatide was approved by the Food and Drug … We evaluated whether early use of this drug was consistent with the FDA-approved indications for use. … The dataset included patients with a diagnosis of DM, or a claim for a drug used to treat DM, between … (San Diego, CA), was approved by the FDA on April 28, 2005. 2 Exenatide is a first-in-class drug that … , he was considered to have been on this drug for that interval.

132. Bone Density | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/bone-density
     April 23, 2019 - bonedensity.html Products Systematic Review Archived April 23, 2019 Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Research … Protocol Archived April 12, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporotic

133. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - Intervention RLS treatment, including both drug therapies and nondrug therapies. … RLS treatment, including both drug therapies and nondrug therapies. … (Both drug and nondrug treatment options could be considered.) Treatment for RLS. … With RLS Drug: SPM 962 NCT00656110 Neuroma Injections to Treat Restless Legs Syndrome - RCT Drug … Drug Interaction Study With Gabapentin Enacarbil and Morphine Drug: morphine; Placebo NCT01516372

134. Migraine-Prevention Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
     June 01, 2013 - , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) improve safety of the treatments … , patient education, drug surveillance, or interactive drug monitoring) influence results? … care, patient education, drug surveillance, or interactive drug monitoring) improve safety of the … Adverse drug reactions and off-label drug use in paediatric outpatients.

135. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - The drug is administered orally, at a dosage of 250 mg, once daily. … Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. 3. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … Aetna non-Medicare prescription drug plan. Subject: cystic fibrosis. [internet]. … Food and Drug Administration (FDA) [accessed 2012 Jun 28]. [2 p].

136. Connective Tissue Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/connective-tissue-disorders
     May 24, 2017 - /connectivetissuedisorders.html Products Research Protocol May 24, 2017 Drug … Rheumatoid Arthritis in Adults: An Update Systematic Review Archived June 1, 2012 Drug … 2006-2009 Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Arthritis Systematic Review Archived November 19, 2007 Comparative Effectiveness of Drug

137. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - The drug has been classified by the U.S. … Drug Enforcement Administration as a Schedule IV drug; it became available for prescribing in June … Health care delivery infrastructure and patient management: As an oral drug, this drug would not significantly … Drug Enforcement Administration (DEA) as a Schedule IV drug (i.e., with a low potential for abuse … FDA approves Qsymia, a weight-loss drug. [internet].

138. S5 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s5.pdf
     October 01, 2007 - Lohr, PhD Background: Interest in new methods for comparative effective- ness, drug and patient safety … structure both interventional and database-oriented studies, particu- larly those concerned with adverse drug … Key Words: comparative effectiveness, drug safety, health care, methods, patient safety, pharmaceuticals … ), trends in evidence-based practice and effective health care, together with Medicare Prescription Drug … L. 108–173), have converged to spotlight issues of drug effec- tiveness and safety.

139. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
     January 28, 2016 - Five third-party payers consider Sovaldi a preferred drug; nine consider Harvoni a preferred drug. … Daklinza purportedly has a low drug-drug interaction profile, which could support its use in patients … Guideline #CG-DRUG-07. [internet]. … Hepatitis virus drug therapy. Drug policy #05.01.50. [internet]. … Specialty drug list. [internet].

140. Medicare Prescription Drug Data Development: Methods for Improving Patient Safety and Pharmacovigilance Using Observational Data | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/patient-safety-databases-prescriptions
     March 01, 2021 - SHARE: Medicare Prescription Drug … originally created December 2020 Internet Citation: Medicare Prescription Drug